Terms: = Brain cancer AND EPS15, AF-1P, 2060, ENSG00000085832, P42566, MLLT5, AF1P AND Treatment
15 results:
1. Invasive Giant Prolactinoma.
Alkhaibary A; Alharbi A; Khairy S
World Neurosurg; 2024 Jan; 181():21-22. PubMed ID: 37827431
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of tumour volume in patients with a poor Karnofsky performance status scale - a bicentric retrospective study.
Barz M; Gerhardt J; Bette S; Aftahy AK; Huber T; Combs SE; Ryang YM; Wiestler B; Skardelly M; Gepfner-Tuma I; Behling F; Schmidt-Graf F; Meyer B; Gempt J
BMC Neurol; 2021 Nov; 21(1):446. PubMed ID: 34781889
[TBL] [Abstract] [Full Text] [Related]
3. Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series.
Montemurro N; Fanelli GN; Scatena C; Ortenzi V; Pasqualetti F; Mazzanti CM; Morganti R; Paiar F; Naccarato AG; Perrini P
Clin Neurol Neurosurg; 2021 Aug; 207():106735. PubMed ID: 34119900
[TBL] [Abstract] [Full Text] [Related]
4. Modulated Electrohyperthermia in Integrative cancer treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study.
Fiorentini G; Sarti D; Milandri C; Dentico P; Mambrini A; Fiorentini C; Mattioli G; Casadei V; Guadagni S
Integr Cancer Ther; 2019; 18():1534735418812691. PubMed ID: 30580645
[TBL] [Abstract] [Full Text] [Related]
5. Present clinical practices of stereotactic irradiation for metastatic brain tumors in Japan: results of questionnaire survey of the Japanese Radiation Oncology Study Group (JROSG) working subgroup for neurological tumors.
Harada K; Igaki H; Abe E; Ariga T; Hayashi N; Kanemoto A; Komiyama T; Matsumoto Y; Nakano T; Onimaru R; Saito H; Sumi M; Tago M; Tanaka K; Maebayashi K; Aoyama H;
Int J Clin Oncol; 2018 Dec; 23(6):1015-1022. PubMed ID: 29971621
[TBL] [Abstract] [Full Text] [Related]
6. Hypermutations in gliomas: a potential immunotherapy target.
Finocchiaro G; Langella T; Corbetta C; Pellegatta S
Discov Med; 2017 Feb; 23(125):113-120. PubMed ID: 28371614
[TBL] [Abstract] [Full Text] [Related]
7. Neurophysiological intraoperative monitoring during an optic nerve schwannoma removal.
San-Juan D; Escanio Cortés M; Tena-Suck M; Orozco Garduño AJ; López Pizano JA; Villanueva Domínguez J; Fernández Gónzalez-Aragón M; Gómez-Amador JL
J Clin Monit Comput; 2017 Oct; 31(5):1059-1064. PubMed ID: 27586244
[TBL] [Abstract] [Full Text] [Related]
8. Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology.
Jung TY; Lee JY; Kim DS; Park HJ; Kim CY; Ra YS; Lee MJ; Kim SH; Baek HJ; Kim IH; Park KD; Kim SK
J Neurooncol; 2015 Jan; 121(2):413-9. PubMed ID: 25366367
[TBL] [Abstract] [Full Text] [Related]
9. Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma.
Schmainda KM; Prah M; Connelly J; Rand SD; Hoffman RG; Mueller W; Malkin MG
Neuro Oncol; 2014 Jun; 16(6):880-8. PubMed ID: 24431219
[TBL] [Abstract] [Full Text] [Related]
10. Imaging and therapy with rituximab anti-CD20 immunotherapy in an animal model of central nervous system lymphoma.
Muldoon LL; Lewin SJ; Dósa E; Kraemer DF; Pagel MA; Doolittle ND; Neuwelt EA
Clin Cancer Res; 2011 Apr; 17(8):2207-15. PubMed ID: 21385922
[TBL] [Abstract] [Full Text] [Related]
11. Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapy.
Adkison JB; Tomé W; Seo S; Richards GM; Robins HI; Rassmussen K; Welsh JS; Mahler PA; Howard SP
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):835-41. PubMed ID: 20472350
[TBL] [Abstract] [Full Text] [Related]
12. Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?
Fokas E; Wacker U; Gross MW; Henzel M; Encheva E; Engenhart-Cabillic R
Strahlenther Onkol; 2009 Apr; 185(4):235-40. PubMed ID: 19370426
[TBL] [Abstract] [Full Text] [Related]
13. Complex juxtapapillary capillary hemangioma: a case report.
Reynolds SA; Shechtman D; Falco L
Optometry; 2008 Sep; 79(9):512-7. PubMed ID: 18722963
[TBL] [Abstract] [Full Text] [Related]
14. 3D conformal radiotherapy and cisplatin for recurrent malignant glioma.
VanderSpek L; Fisher B; Bauman G; Macdonald D
Can J Neurol Sci; 2008 Mar; 35(1):57-64. PubMed ID: 18380278
[TBL] [Abstract] [Full Text] [Related]
15. Responsiveness of growth hormone-deficient children to human growth hormone. Effect of replacement therapy for one year.
Rudman D; Patterson JH; Gibbas DL
J Clin Invest; 1973 May; 52(5):1108-12. PubMed ID: 4700485
[TBL] [Abstract] [Full Text] [Related]
